Capital markets / Biotechnology
Alector prices a 36,600,000-share offering at $2.05, a 7.3% premium to its Oct. 15 close
Expected gross proceeds are $75,030,000.00 before fees, and the underwriters pay Alector $1.927 a share, about $0.12 below the public price. Closing is expected on or about October 19, 2026.